FREQ Frequency Therapeutics, Inc.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean in November 13, 2014 and is headquartered in Woburn, MA.

$52.23  +3.70 (7.62%)
As of 02/24/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
10/03/2019
33,734,692
311,189
$1,637,144,603
0.00%
SEC Edgar Online
10-Q
10-K
35803L108
US35803L1089
BJVRDQ9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-75.06
8.20
51.58
-10.91%
-68.59%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy